Información de la revista
Vol. 47. Núm. 4.
Páginas 243 (Abril 2023)
Images in Intensive Medicine
Acceso a texto completo
Fibrinolytic treatment with tissue plasminogen activator in a patient with massive pulmonary thromboembolism and bidirectional Glenn procedure
Tratamiento fibrinolítico con activador tisular del plasminógeno en paciente con tromboembolismo pulmonar masivo y trombosis de la anastomosis de Glenn
Visitas
2204
M. Cuervas-Mons Tejedor, J.D. López Castilla
Autor para correspondencia
pepedomi1953@gmail.com

Corresponding author.
, E. Sánchez Valderrábanos
Unidad de Gestión Clínica de Cuidados Intensivos Pediátricos. Hospital Infantil Virgen del Rocío, Sevilla. Spain
Este artículo ha recibido
Información del artículo
Texto completo
Descargar PDF
Estadísticas
Figuras (2)
Texto completo

A 16-year-old female presented with a history of complex congenital heart disease requiring a right systemic-pulmonary fistula, with a bidirectional cavopulmonary anastomosis (Glenn procedure) at 6 years of age. She was admitted to the Pediatric Intensive Care Unit due to breathing difficulty and severe hypoxemia. With the suspicion of pulmonary thromboembolism, heparin sodium was started, and a new CT angiographic study was performed 24 hours later due to progressive clinical worsening. A thrombus was identified at the communication between the left superior vena cava and the left pulmonary artery, compatible with massive thromboembolism of the left lung (Fig. 1, see arrows). Treatment was started with recombinant tissue plasminogen activator (rTPA) in the form of an initial 30 mg bolus (0.5 mg/kg) followed by the perfusion of 0.04 mg/kg/h. After 36 hours, repeat control CT angiography evidenced important thrombus reduction with marked re-permeation (Fig. 2, see arrows).

Fig. 1
Fig. 2
Funding

The authors declare that no funding has been received for this study.

Copyright © 2021. Elsevier España, S.L.U. and SEMICYUC
Descargar PDF
Idiomas
Medicina Intensiva
Opciones de artículo
Herramientas